| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | chromatin binding | 4.76e-06 | 739 | 36 | 9 | GO:0003682 | |
| GeneOntologyMolecularFunction | histone binding | 7.20e-06 | 265 | 36 | 6 | GO:0042393 | |
| GeneOntologyMolecularFunction | phosphatase regulator activity | 4.98e-05 | 113 | 36 | 4 | GO:0019208 | |
| GeneOntologyMolecularFunction | phosphatase inhibitor activity | 1.25e-04 | 54 | 36 | 3 | GO:0019212 | |
| GeneOntologyMolecularFunction | histone modifying activity | 7.44e-04 | 229 | 36 | 4 | GO:0140993 | |
| GeneOntologyMolecularFunction | protein phosphatase regulator activity | 7.72e-04 | 100 | 36 | 3 | GO:0019888 | |
| GeneOntologyMolecularFunction | RNA polymerase II core promoter sequence-specific DNA binding | 9.24e-04 | 25 | 36 | 2 | GO:0000979 | |
| GeneOntologyBiologicalProcess | chromatin organization | 1.35e-05 | 896 | 35 | 9 | GO:0006325 | |
| GeneOntologyBiologicalProcess | protein-DNA complex organization | 3.19e-05 | 999 | 35 | 9 | GO:0071824 | |
| GeneOntologyBiologicalProcess | negative regulation of DNA-templated transcription | 7.64e-05 | 1399 | 35 | 10 | GO:0045892 | |
| GeneOntologyBiologicalProcess | negative regulation of RNA biosynthetic process | 8.31e-05 | 1413 | 35 | 10 | GO:1902679 | |
| GeneOntologyBiologicalProcess | head development | 1.21e-04 | 919 | 35 | 8 | GO:0060322 | |
| GeneOntologyBiologicalProcess | chromatin remodeling | 2.10e-04 | 741 | 35 | 7 | GO:0006338 | |
| GeneOntologyBiologicalProcess | regulation of muscle cell differentiation | 3.48e-04 | 199 | 35 | 4 | GO:0051147 | |
| GeneOntologyBiologicalProcess | negative regulation of muscle cell differentiation | 3.75e-04 | 83 | 35 | 3 | GO:0051148 | |
| GeneOntologyCellularComponent | chromatin | MYT1L NKX1-1 ANP32E SOX12 CHD8 SET HMX1 EZH2 CENPB SETSIP HDAC1 KAT6A | 3.84e-06 | 1480 | 36 | 12 | GO:0000785 |
| Domain | ARM-type_fold | 2.65e-06 | 339 | 35 | 7 | IPR016024 | |
| Domain | ARM-like | 9.85e-06 | 270 | 35 | 6 | IPR011989 | |
| Domain | NAP | 4.56e-04 | 17 | 35 | 2 | PF00956 | |
| Domain | NAP_family | 4.56e-04 | 17 | 35 | 2 | IPR002164 | |
| Domain | HECT | 1.16e-03 | 27 | 35 | 2 | PF00632 | |
| Domain | HECTc | 1.16e-03 | 27 | 35 | 2 | SM00119 | |
| Domain | HECT_dom | 1.16e-03 | 27 | 35 | 2 | IPR000569 | |
| Domain | HECT | 1.16e-03 | 27 | 35 | 2 | PS50237 | |
| Domain | Armadillo | 3.50e-03 | 47 | 35 | 2 | IPR000225 | |
| Domain | - | 8.19e-03 | 222 | 35 | 3 | 1.25.10.10 | |
| Domain | Homeobox_metazoa | 1.23e-02 | 90 | 35 | 2 | IPR020479 | |
| Pubmed | ZMYM3 regulates BRCA1 localization at damaged chromatin to promote DNA repair. | 1.02e-08 | 150 | 36 | 6 | 28242625 | |
| Pubmed | A high-throughput approach for measuring temporal changes in the interactome. | ANP32E SET NCL PDE3A ARMC9 HUWE1 ARIH1 HNRNPUL2 HECTD1 SETSIP PPP4R3A HDAC1 | 1.35e-08 | 1455 | 36 | 12 | 22863883 |
| Pubmed | ANP32E CHD8 SET NCL DDX46 ARIH1 CENPB HNRNPUL2 PPP4R3A HDAC1 | 5.42e-08 | 1014 | 36 | 10 | 32416067 | |
| Pubmed | 2.89e-07 | 13 | 36 | 3 | 19836239 | ||
| Pubmed | Mapping the Ku Interactome Using Proximity-Dependent Biotin Identification in Human Cells. | 4.37e-07 | 283 | 36 | 6 | 30585729 | |
| Pubmed | The E3 ubiquitin ligase HECTD1 contributes to cell proliferation through an effect on mitosis. | 8.74e-07 | 759 | 36 | 8 | 35915203 | |
| Pubmed | 2.31e-06 | 377 | 36 | 6 | 25147182 | ||
| Pubmed | 3.12e-06 | 3 | 36 | 2 | 12900441 | ||
| Pubmed | A systems-wide screen identifies substrates of the SCFβTrCP ubiquitin ligase. | 4.03e-06 | 232 | 36 | 5 | 25515538 | |
| Pubmed | BTB-ZF factors recruit the E3 ligase cullin 3 to regulate lymphoid effector programs. | 4.49e-06 | 31 | 36 | 3 | 23086144 | |
| Pubmed | Reciprocal interaction between SIRT6 and APC/C regulates genomic stability. | 5.60e-06 | 440 | 36 | 6 | 34244565 | |
| Pubmed | BAP1 regulation of the key adaptor protein NCoR1 is critical for γ-globin gene repression. | 5.85e-06 | 1318 | 36 | 9 | 30463901 | |
| Pubmed | Ezh2 reduces the ability of HDAC1-dependent pRb2/p130 transcriptional repression of cyclin A. | 6.24e-06 | 4 | 36 | 2 | 15077161 | |
| Pubmed | 6.24e-06 | 4 | 36 | 2 | 21423269 | ||
| Pubmed | 6.24e-06 | 4 | 36 | 2 | 23677067 | ||
| Pubmed | 6.24e-06 | 4 | 36 | 2 | 30818224 | ||
| Pubmed | A Chemical Proteomics Approach to Reveal Direct Protein-Protein Interactions in Living Cells. | 6.52e-06 | 35 | 36 | 3 | 29104064 | |
| Pubmed | Myt1 family recruits histone deacetylase to regulate neural transcription. | 1.04e-05 | 5 | 36 | 2 | 15935060 | |
| Pubmed | 1.04e-05 | 5 | 36 | 2 | 15520282 | ||
| Pubmed | Selective requirement of H2B N-Terminal tail for p14ARF-induced chromatin silencing. | 1.04e-05 | 5 | 36 | 2 | 21846774 | |
| Pubmed | Epigenetic silencing of myogenic gene program by Myb-binding protein 1a suppresses myogenesis. | 1.04e-05 | 5 | 36 | 2 | 22333916 | |
| Pubmed | 1.04e-05 | 5 | 36 | 2 | 28425671 | ||
| Pubmed | 1.04e-05 | 5 | 36 | 2 | 10581039 | ||
| Pubmed | 1.04e-05 | 5 | 36 | 2 | 34518534 | ||
| Pubmed | Blocking an N-terminal acetylation-dependent protein interaction inhibits an E3 ligase. | 1.09e-05 | 495 | 36 | 6 | 28581483 | |
| Pubmed | 1.20e-05 | 503 | 36 | 6 | 16964243 | ||
| Pubmed | 1.56e-05 | 6 | 36 | 2 | 21685935 | ||
| Pubmed | 1.56e-05 | 6 | 36 | 2 | 31863900 | ||
| Pubmed | Tumor suppressor BAP1 nuclear import is governed by transportin-1. | 1.84e-05 | 1149 | 36 | 8 | 35446349 | |
| Pubmed | 2.10e-05 | 157 | 36 | 4 | 30186101 | ||
| Pubmed | Transcription factors LRF and BCL11A independently repress expression of fetal hemoglobin. | 2.18e-05 | 7 | 36 | 2 | 26816381 | |
| Pubmed | FE65 binds Teashirt, inhibiting expression of the primate-specific caspase-4. | 2.18e-05 | 7 | 36 | 2 | 19343227 | |
| Pubmed | 2.37e-05 | 335 | 36 | 5 | 15741177 | ||
| Pubmed | 2.87e-05 | 57 | 36 | 3 | 21122108 | ||
| Pubmed | 2.87e-05 | 57 | 36 | 3 | 38223760 | ||
| Pubmed | 2.91e-05 | 8 | 36 | 2 | 16565076 | ||
| Pubmed | Enhancer Activity Requires CBP/P300 Bromodomain-Dependent Histone H3K27 Acetylation. | 3.59e-05 | 180 | 36 | 4 | 30110629 | |
| Pubmed | TET1 regulates fibroblast growth factor 8 transcription in gonadotropin releasing hormone neurons. | 3.73e-05 | 9 | 36 | 2 | 31361780 | |
| Pubmed | 3.73e-05 | 9 | 36 | 2 | 31130994 | ||
| Pubmed | 3.73e-05 | 9 | 36 | 2 | 24771265 | ||
| Pubmed | The role of WDR5 in silencing human fetal globin gene expression. | 3.73e-05 | 9 | 36 | 2 | 22689669 | |
| Pubmed | 4.06e-05 | 64 | 36 | 3 | 22865885 | ||
| Pubmed | K63 ubiquitylation triggers proteasomal degradation by seeding branched ubiquitin chains. | 4.26e-05 | 65 | 36 | 3 | 29378950 | |
| Pubmed | 4.52e-05 | 191 | 36 | 4 | 20195357 | ||
| Pubmed | 4.54e-05 | 638 | 36 | 6 | 33239621 | ||
| Pubmed | 4.66e-05 | 67 | 36 | 3 | 16226712 | ||
| Pubmed | 4.66e-05 | 10 | 36 | 2 | 36635505 | ||
| Pubmed | 4.90e-05 | 195 | 36 | 4 | 19454010 | ||
| Pubmed | 5.05e-05 | 963 | 36 | 7 | 28671696 | ||
| Pubmed | WDR76 Co-Localizes with Heterochromatin Related Proteins and Rapidly Responds to DNA Damage. | 5.14e-05 | 394 | 36 | 5 | 27248496 | |
| Pubmed | The ubiquitin-dependent ATPase p97 removes cytotoxic trapped PARP1 from chromatin. | 5.52e-05 | 400 | 36 | 5 | 35013556 | |
| Pubmed | 5.70e-05 | 11 | 36 | 2 | 12834871 | ||
| Pubmed | 5.70e-05 | 11 | 36 | 2 | 22439931 | ||
| Pubmed | 5.70e-05 | 11 | 36 | 2 | 29263092 | ||
| Pubmed | An H3K36 methylation-engaging Tudor motif of polycomb-like proteins mediates PRC2 complex targeting. | 5.70e-05 | 11 | 36 | 2 | 23273982 | |
| Pubmed | 5.78e-05 | 72 | 36 | 3 | 31248990 | ||
| Pubmed | Proteome-wide identification of HSP70/HSC70 chaperone clients in human cells. | 6.32e-05 | 1367 | 36 | 8 | 32687490 | |
| Pubmed | 6.53e-05 | 75 | 36 | 3 | 25593309 | ||
| Pubmed | 6.72e-05 | 417 | 36 | 5 | 36537216 | ||
| Pubmed | 6.79e-05 | 418 | 36 | 5 | 34709266 | ||
| Pubmed | De novo genic mutations among a Chinese autism spectrum disorder cohort. | 6.83e-05 | 12 | 36 | 2 | 27824329 | |
| Pubmed | 6.83e-05 | 12 | 36 | 2 | 15136563 | ||
| Pubmed | 8.07e-05 | 13 | 36 | 2 | 34619150 | ||
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | 8.45e-05 | 1425 | 36 | 8 | 30948266 | |
| Pubmed | Detection of differentially expressed genes in the early developmental stage of the mouse mandible. | 1.08e-04 | 15 | 36 | 2 | 11461004 | |
| Pubmed | ATRX proximal protein associations boast roles beyond histone deposition. | 1.16e-04 | 91 | 36 | 3 | 34780483 | |
| Pubmed | Scanning the human proteome for calmodulin-binding proteins. | 1.20e-04 | 92 | 36 | 3 | 15840729 | |
| Pubmed | 1.27e-04 | 1116 | 36 | 7 | 31753913 | ||
| Pubmed | Activity-based E3 ligase profiling uncovers an E3 ligase with esterification activity. | 1.32e-04 | 95 | 36 | 3 | 29643511 | |
| Pubmed | A method to identify cDNAs based on localization of green fluorescent protein fusion products. | 1.40e-04 | 17 | 36 | 2 | 10716735 | |
| Pubmed | Affinity purification strategies for proteomic analysis of transcription factor complexes. | 1.40e-04 | 97 | 36 | 3 | 23937658 | |
| Pubmed | 1.43e-04 | 786 | 36 | 6 | 29128334 | ||
| Pubmed | 1.58e-04 | 18 | 36 | 2 | 35411049 | ||
| Pubmed | Proteolysis of methylated SOX2 protein is regulated by L3MBTL3 and CRL4DCAF5 ubiquitin ligase. | 1.76e-04 | 19 | 36 | 2 | 30442713 | |
| Pubmed | 2.13e-04 | 534 | 36 | 5 | 35032548 | ||
| Pubmed | Identification of novel ARF binding proteins by two-hybrid screening. | 2.16e-04 | 21 | 36 | 2 | 16582619 | |
| Pubmed | 2.38e-04 | 22 | 36 | 2 | 14645517 | ||
| Pubmed | 2.60e-04 | 23 | 36 | 2 | 21937600 | ||
| Pubmed | 2.70e-04 | 121 | 36 | 3 | 22412018 | ||
| Pubmed | 3.08e-04 | 25 | 36 | 2 | 30541888 | ||
| Pubmed | System-Wide Modulation of HECT E3 Ligases with Selective Ubiquitin Variant Probes. | 3.33e-04 | 26 | 36 | 2 | 26949039 | |
| Pubmed | ZBTB2 protein is a new partner of the Nucleosome Remodeling and Deacetylase (NuRD) complex. | 3.69e-04 | 330 | 36 | 4 | 33301849 | |
| Pubmed | 3.77e-04 | 332 | 36 | 4 | 37433992 | ||
| Pubmed | 3.80e-04 | 1335 | 36 | 7 | 29229926 | ||
| Pubmed | The in vivo Interaction Landscape of Histones H3.1 and H3.3. | 3.87e-04 | 608 | 36 | 5 | 36089195 | |
| Pubmed | TBK1 phosphorylation activates LIR-dependent degradation of the inflammation repressor TNIP1. | 3.93e-04 | 949 | 36 | 6 | 36574265 | |
| Pubmed | 4.14e-04 | 140 | 36 | 3 | 26930384 | ||
| Pubmed | LCP1 preferentially binds clasped αMβ2 integrin and attenuates leukocyte adhesion under flow. | 4.32e-04 | 344 | 36 | 4 | 30333137 | |
| Pubmed | ALS/FTD-causing mutation in cyclin F causes the dysregulation of SFPQ. | 4.35e-04 | 624 | 36 | 5 | 33729478 | |
| Pubmed | 4.45e-04 | 30 | 36 | 2 | 35830813 | ||
| Pubmed | 4.75e-04 | 31 | 36 | 2 | 29846670 | ||
| Pubmed | LGALS3BP regulates centriole biogenesis and centrosome hypertrophy in cancer cells. | 4.85e-04 | 639 | 36 | 5 | 23443559 | |
| Pubmed | HIV-1 Vpr induces cell cycle arrest and enhances viral gene expression by depleting CCDC137. | 4.86e-04 | 148 | 36 | 3 | 32538781 | |
| Pubmed | Defining the human deubiquitinating enzyme interaction landscape. | 5.32e-04 | 1005 | 36 | 6 | 19615732 | |
| Pubmed | 5.35e-04 | 653 | 36 | 5 | 22586326 | ||
| Pubmed | Systematic identification of factors for provirus silencing in embryonic stem cells. | 5.36e-04 | 153 | 36 | 3 | 26365490 | |
| Pubmed | Assembly of the U5 snRNP component PRPF8 is controlled by the HSP90/R2TP chaperones. | 5.38e-04 | 1415 | 36 | 7 | 28515276 | |
| Pubmed | 5.39e-04 | 33 | 36 | 2 | 26296893 | ||
| Pubmed | Multiplexed barcoded CRISPR-Cas9 screening enabled by CombiGEM. | 5.39e-04 | 33 | 36 | 2 | 26864203 | |
| Pubmed | 5.43e-04 | 655 | 36 | 5 | 35819319 | ||
| Interaction | MACROH2A1 interactions | 4.99e-09 | 458 | 36 | 10 | int:MACROH2A1 | |
| Interaction | SRP9 interactions | 6.84e-07 | 427 | 36 | 8 | int:SRP9 | |
| Interaction | HNRNPUL2 interactions | 7.10e-07 | 291 | 36 | 7 | int:HNRNPUL2 | |
| Interaction | DDX47 interactions | 8.82e-07 | 186 | 36 | 6 | int:DDX47 | |
| Interaction | CTCF interactions | 1.22e-06 | 461 | 36 | 8 | int:CTCF | |
| Interaction | SMC2 interactions | 1.43e-06 | 323 | 36 | 7 | int:SMC2 | |
| Interaction | RCOR1 interactions | 2.04e-06 | 494 | 36 | 8 | int:RCOR1 | |
| Interaction | WDR18 interactions | 3.71e-06 | 133 | 36 | 5 | int:WDR18 | |
| Interaction | KPNB1 interactions | 4.16e-06 | 544 | 36 | 8 | int:KPNB1 | |
| Interaction | H4C16 interactions | 7.13e-06 | 152 | 36 | 5 | int:H4C16 | |
| Interaction | MSH6 interactions | 7.77e-06 | 271 | 36 | 6 | int:MSH6 | |
| Interaction | SETSIP interactions | 1.17e-05 | 25 | 36 | 3 | int:SETSIP | |
| Interaction | FARSB interactions | 1.26e-05 | 171 | 36 | 5 | int:FARSB | |
| Interaction | DANCR interactions | 1.32e-05 | 26 | 36 | 3 | int:DANCR | |
| Interaction | CPSF2 interactions | 1.34e-05 | 173 | 36 | 5 | int:CPSF2 | |
| Interaction | SUZ12 interactions | 1.43e-05 | 644 | 36 | 8 | int:SUZ12 | |
| Interaction | KMT2A interactions | 1.79e-05 | 314 | 36 | 6 | int:KMT2A | |
| Interaction | HSPA4 interactions | 1.84e-05 | 667 | 36 | 8 | int:HSPA4 | |
| Interaction | CHAF1A interactions | 2.06e-05 | 322 | 36 | 6 | int:CHAF1A | |
| Interaction | MGMT interactions | 2.14e-05 | 92 | 36 | 4 | int:MGMT | |
| Interaction | POLR1G interactions | 2.15e-05 | 489 | 36 | 7 | int:POLR1G | |
| Interaction | DCTN1 interactions | 2.39e-05 | 497 | 36 | 7 | int:DCTN1 | |
| Interaction | H2BC21 interactions | 2.50e-05 | 696 | 36 | 8 | int:H2BC21 | |
| Interaction | XRCC6 interactions | 2.74e-05 | 928 | 36 | 9 | int:XRCC6 | |
| Interaction | TERF2 interactions | 2.80e-05 | 340 | 36 | 6 | int:TERF2 | |
| Interaction | NAP1L1 interactions | 3.04e-05 | 345 | 36 | 6 | int:NAP1L1 | |
| Interaction | PRKACA interactions | 3.15e-05 | 519 | 36 | 7 | int:PRKACA | |
| Interaction | KPNA2 interactions | 3.15e-05 | 519 | 36 | 7 | int:KPNA2 | |
| Interaction | ABCF2 interactions | 3.32e-05 | 209 | 36 | 5 | int:ABCF2 | |
| Interaction | DEK interactions | 3.32e-05 | 209 | 36 | 5 | int:DEK | |
| Interaction | DNAJA1 interactions | 3.73e-05 | 533 | 36 | 7 | int:DNAJA1 | |
| Interaction | MYH10 interactions | 3.80e-05 | 359 | 36 | 6 | int:MYH10 | |
| Interaction | HNRNPR interactions | 3.87e-05 | 536 | 36 | 7 | int:HNRNPR | |
| Interaction | NUCKS1 interactions | 4.24e-05 | 220 | 36 | 5 | int:NUCKS1 | |
| Interaction | TASOR interactions | 4.33e-05 | 110 | 36 | 4 | int:TASOR | |
| Interaction | HECTD1 interactions | 4.34e-05 | 984 | 36 | 9 | int:HECTD1 | |
| Interaction | HNRNPA2B1 interactions | 4.41e-05 | 754 | 36 | 8 | int:HNRNPA2B1 | |
| Interaction | ZNF326 interactions | 4.62e-05 | 224 | 36 | 5 | int:ZNF326 | |
| Interaction | KPNA4 interactions | 4.72e-05 | 225 | 36 | 5 | int:KPNA4 | |
| Interaction | CTNNB1 interactions | 5.28e-05 | 1009 | 36 | 9 | int:CTNNB1 | |
| Interaction | AHCYL1 interactions | 5.85e-05 | 388 | 36 | 6 | int:AHCYL1 | |
| Interaction | RUVBL1 interactions | 6.03e-05 | 575 | 36 | 7 | int:RUVBL1 | |
| Interaction | CENPV interactions | 6.28e-05 | 121 | 36 | 4 | int:CENPV | |
| Interaction | PSMC2 interactions | 6.28e-05 | 393 | 36 | 6 | int:PSMC2 | |
| Interaction | PNMA8A interactions | 6.48e-05 | 122 | 36 | 4 | int:PNMA8A | |
| Interaction | KIF2A interactions | 6.66e-05 | 242 | 36 | 5 | int:KIF2A | |
| Interaction | L3MBTL3 interactions | 6.69e-05 | 123 | 36 | 4 | int:L3MBTL3 | |
| Interaction | IQGAP1 interactions | 7.17e-05 | 591 | 36 | 7 | int:IQGAP1 | |
| Interaction | SUMO2 interactions | 7.17e-05 | 591 | 36 | 7 | int:SUMO2 | |
| Interaction | KPNA3 interactions | 7.48e-05 | 248 | 36 | 5 | int:KPNA3 | |
| Interaction | CMAS interactions | 7.58e-05 | 127 | 36 | 4 | int:CMAS | |
| Interaction | SNRPD2 interactions | 8.38e-05 | 414 | 36 | 6 | int:SNRPD2 | |
| Interaction | SMARCA5 interactions | 8.49e-05 | 415 | 36 | 6 | int:SMARCA5 | |
| Interaction | NFE4 interactions | 8.63e-05 | 8 | 36 | 2 | int:NFE4 | |
| Interaction | FTSJ3 interactions | 9.30e-05 | 422 | 36 | 6 | int:FTSJ3 | |
| Interaction | UPF3B interactions | 9.88e-05 | 136 | 36 | 4 | int:UPF3B | |
| Interaction | BIRC6 interactions | 1.02e-04 | 265 | 36 | 5 | int:BIRC6 | |
| Interaction | SLC25A5 interactions | 1.04e-04 | 431 | 36 | 6 | int:SLC25A5 | |
| Interaction | RPL27 interactions | 1.04e-04 | 431 | 36 | 6 | int:RPL27 | |
| Interaction | NIFK interactions | 1.04e-04 | 431 | 36 | 6 | int:NIFK | |
| Interaction | SIRT6 interactions | 1.05e-04 | 628 | 36 | 7 | int:SIRT6 | |
| Interaction | CDC5L interactions | 1.07e-04 | 855 | 36 | 8 | int:CDC5L | |
| Interaction | HUWE1 interactions | 1.10e-04 | 1110 | 36 | 9 | int:HUWE1 | |
| Interaction | RPL22 interactions | 1.17e-04 | 440 | 36 | 6 | int:RPL22 | |
| Interaction | EIF2S1 interactions | 1.24e-04 | 276 | 36 | 5 | int:EIF2S1 | |
| Interaction | RPL18A interactions | 1.28e-04 | 447 | 36 | 6 | int:RPL18A | |
| Interaction | NSD2 interactions | 1.28e-04 | 278 | 36 | 5 | int:NSD2 | |
| Interaction | H3-4 interactions | 1.29e-04 | 448 | 36 | 6 | int:H3-4 | |
| Interaction | HSPH1 interactions | 1.29e-04 | 448 | 36 | 6 | int:HSPH1 | |
| Interaction | UBE2M interactions | 1.31e-04 | 651 | 36 | 7 | int:UBE2M | |
| Interaction | U2AF2 interactions | 1.31e-04 | 651 | 36 | 7 | int:U2AF2 | |
| Interaction | PRPF19 interactions | 1.32e-04 | 450 | 36 | 6 | int:PRPF19 | |
| Interaction | ITSN2 interactions | 1.33e-04 | 147 | 36 | 4 | int:ITSN2 | |
| Interaction | EIF3H interactions | 1.37e-04 | 282 | 36 | 5 | int:EIF3H | |
| Interaction | BOD1L1 interactions | 1.41e-04 | 149 | 36 | 4 | int:BOD1L1 | |
| Interaction | H3C1 interactions | 1.53e-04 | 901 | 36 | 8 | int:H3C1 | |
| Interaction | ACTL6A interactions | 1.53e-04 | 289 | 36 | 5 | int:ACTL6A | |
| Interaction | OBSL1 interactions | 1.54e-04 | 902 | 36 | 8 | int:OBSL1 | |
| Interaction | FYTTD1 interactions | 1.60e-04 | 154 | 36 | 4 | int:FYTTD1 | |
| Interaction | DNAJC9 interactions | 1.72e-04 | 296 | 36 | 5 | int:DNAJC9 | |
| Interaction | FBXW11 interactions | 1.73e-04 | 473 | 36 | 6 | int:FBXW11 | |
| Interaction | ZNF593 interactions | 1.75e-04 | 61 | 36 | 3 | int:ZNF593 | |
| Interaction | RAN interactions | 1.77e-04 | 475 | 36 | 6 | int:RAN | |
| Interaction | WDR43 interactions | 1.81e-04 | 159 | 36 | 4 | int:WDR43 | |
| Interaction | GAPDH interactions | 1.81e-04 | 686 | 36 | 7 | int:GAPDH | |
| Interaction | EXOSC9 interactions | 1.94e-04 | 162 | 36 | 4 | int:EXOSC9 | |
| Interaction | CRY1 interactions | 1.94e-04 | 162 | 36 | 4 | int:CRY1 | |
| Interaction | CHD4 interactions | 2.02e-04 | 938 | 36 | 8 | int:CHD4 | |
| Interaction | KDM1A interactions | 2.07e-04 | 941 | 36 | 8 | int:KDM1A | |
| Interaction | RPS13 interactions | 2.08e-04 | 489 | 36 | 6 | int:RPS13 | |
| Interaction | CDK5R1 interactions | 2.12e-04 | 65 | 36 | 3 | int:CDK5R1 | |
| Interaction | RACK1 interactions | 2.12e-04 | 704 | 36 | 7 | int:RACK1 | |
| Interaction | PHAX interactions | 2.18e-04 | 167 | 36 | 4 | int:PHAX | |
| Interaction | MORF4L2 interactions | 2.23e-04 | 168 | 36 | 4 | int:MORF4L2 | |
| Interaction | TUBA1B interactions | 2.29e-04 | 498 | 36 | 6 | int:TUBA1B | |
| Interaction | PHF5A interactions | 2.38e-04 | 171 | 36 | 4 | int:PHF5A | |
| Interaction | RPS11 interactions | 2.47e-04 | 505 | 36 | 6 | int:RPS11 | |
| Interaction | BCKDHB interactions | 2.53e-04 | 69 | 36 | 3 | int:BCKDHB | |
| Interaction | KAT6A interactions | 2.61e-04 | 510 | 36 | 6 | int:KAT6A | |
| Interaction | RPL18 interactions | 2.66e-04 | 512 | 36 | 6 | int:RPL18 | |
| Cytoband | 20p13 | 7.21e-05 | 102 | 36 | 3 | 20p13 | |
| Cytoband | 2q37.1 | 1.28e-03 | 67 | 36 | 2 | 2q37.1 | |
| GeneFamily | Zinc fingers C2HC-type|PHD finger proteins|Lysine acetyltransferases | 1.84e-04 | 16 | 23 | 2 | 66 | |
| GeneFamily | NKL subclass homeoboxes and pseudogenes | 3.25e-03 | 67 | 23 | 2 | 519 | |
| GeneFamily | Armadillo repeat containing|Protein phosphatase 1 regulatory subunits | 2.20e-02 | 181 | 23 | 2 | 694 | |
| ToppCell | COVID-19_Mild-Neu_4|COVID-19_Mild / 5 Neutrophil clusters in COVID-19 patients | 1.53e-05 | 187 | 36 | 4 | 714851e757c71c559ee6413a3f61d6c117c79ad2 | |
| ToppCell | E12.5|World / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.77e-05 | 194 | 36 | 4 | 4b335e4da58de1cd94194dc4208ce83854e5e50a | |
| ToppCell | PND03-Endothelial-Endothelial_blood-vessel-Microvascular_EC-EPC|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.77e-05 | 194 | 36 | 4 | 3a49c7c86036e09a8cd0114988380d04ad1a26fb | |
| ToppCell | E12.5-Mesenchymal-developing_mesenchymal_cell|E12.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.81e-05 | 195 | 36 | 4 | 97b2ff072cc830a4a2cb217f5a215ca6cad505ec | |
| ToppCell | PND03-Endothelial-Endothelial_blood-vessel-Microvascular_EC-EPC-EPC_G2M|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.81e-05 | 195 | 36 | 4 | 5790b47b0e028e49b99bda8d6d9e80ac79208cdf | |
| ToppCell | PND10-Endothelial-Endothelial_blood-vessel-Microvascular_EC-EPC|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.84e-05 | 196 | 36 | 4 | 0644bd14a944b9c9759a295dfdd5e67a4775f20a | |
| ToppCell | E12.5-Mesenchymal-developing_mesenchymal_cell-mesenchymal_proliferating_cell|E12.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.84e-05 | 196 | 36 | 4 | 62b2de1d38a99ab23211bf51595845f8a1fdb7d2 | |
| ToppCell | HSPCs|World / Lineage and Cell class | 1.96e-05 | 199 | 36 | 4 | df1ffc416c6946f1ba182f242a50ee41a571d565 | |
| ToppCell | 3'-Child04-06-SmallIntestine-Hematopoietic-B_cells-Cycling_B_cell|Child04-06 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.96e-05 | 199 | 36 | 4 | 8b7f84a1e385c6a9bd45a5d41f75e30819dbe32d | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_convalescent_d42-56-Myeloid-Granulocytic-Neutrophil-Neu_c2-CXCR4(low)|Severe-critical_convalescent_d42-56 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.12e-04 | 144 | 36 | 3 | 3d880c140db4a0e7602bfddcb73a42a68c2848d5 | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Vip-Vip_Lmo1_Fam159b|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 2.35e-04 | 149 | 36 | 3 | 98ae408d2d0347865875ff8bbd89d359decea526 | |
| ToppCell | severe_influenza-CD8+_T_naive|World / disease group, cell group and cell class (v2) | 2.89e-04 | 160 | 36 | 3 | a1181ef36b453eba53b04d836aa9f65a71354cdb | |
| ToppCell | severe_influenza-CD8+_T_naive|severe_influenza / disease group, cell group and cell class (v2) | 2.94e-04 | 161 | 36 | 3 | 82196139cdbbd70a36957a87bc9ac6d02575da3f | |
| ToppCell | facs-Marrow-T-cells-24m-Lymphocytic-late_pro-B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.11e-04 | 164 | 36 | 3 | 95ce619ebf0cf5716b099fdc71267313f9dc9d32 | |
| ToppCell | facs-Marrow-T-cells-24m-Lymphocytic-late_pro_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.11e-04 | 164 | 36 | 3 | d0a7e8a7c530f8d7224b50f2abe3d3642fac142b | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2-Inh_L1-3_VIP_CCDC184|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.28e-04 | 167 | 36 | 3 | ef3ef83c213e818597600da15764c5b37763d7b6 | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Vip-Vip_Arhgap36_Hmcn1|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 3.28e-04 | 167 | 36 | 3 | 1c1b4722c6c0eff85a9b32ca7b4e281caebf63b0 | |
| ToppCell | P15-Epithelial-airway_epithelial_cell-ciliated_cell_of_airway|P15 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 3.28e-04 | 167 | 36 | 3 | 5c3d0763f73628c71c71f9883556bb4f1639f3cc | |
| ToppCell | TCGA-Uvea-Primary_Tumor-Uveal_Melanoma-Spindle_Cell-1|TCGA-Uvea / Sample_Type by Project: Shred V9 | 3.34e-04 | 168 | 36 | 3 | b427746929bb40e3d1b5f1c40d302b792d6b32a5 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_1-Inh_L1-2_VIP_RPL41P3|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.45e-04 | 170 | 36 | 3 | 31e3f57673c99f4d8ef30faa9c40e5f7f5bf6460 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_1-Inh_L1-3_VIP_ACHE|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.45e-04 | 170 | 36 | 3 | 36dbbdb13f69307afd2122ff051b2980850c1f00 | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Vip|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 3.57e-04 | 172 | 36 | 3 | 7e1a7700a4c2b1d100da1d6e475e73498ebb605a | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-late_pro-B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.70e-04 | 174 | 36 | 3 | 021ebc6ec022b992d7b25333ba0b7416371e041b | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2-Inh_L3-6_VIP_KCTD13|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.70e-04 | 174 | 36 | 3 | 62f5dc7086e1491fc90f005ccadfa1b772b52fad | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-late_pro_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.70e-04 | 174 | 36 | 3 | c2fc78dd6c440737ded59676961e4c7b923084ce | |
| ToppCell | PND01-Endothelial-Endothelial_blood-vessel-Microvascular_EC-EPC-EPC_G2M|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.82e-04 | 176 | 36 | 3 | 8385435074cc5235b7af7424974f609388fc2cff | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2-Inh_L2-5_VIP_TOX2|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.88e-04 | 177 | 36 | 3 | 85e270b4a0b0da77ffe5987a099e827c02a4adf3 | |
| ToppCell | (01)_Cycling_Basal_(homeostasis)|World / shred by cell type and Timepoint | 3.88e-04 | 177 | 36 | 3 | 05c57578142a6662f18b294d5cc11e6efd6b0f8e | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_2-Inh_L3-6_PVALB_MFI2_(Chandelier_2)|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.88e-04 | 177 | 36 | 3 | 4d67e24653caa318039870114849426ff2582e0c | |
| ToppCell | PND14-Endothelial-Endothelial_blood-vessel-Microvascular_EC-EPC|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.01e-04 | 179 | 36 | 3 | 54191c00b29f53b520cd3243b5791daa4a2c72d7 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2-Inh_L2-4_VIP_LGI2|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.01e-04 | 179 | 36 | 3 | 8dd10e3a9ab39d9a770cecac6e2ed3676b79e906 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_2|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.01e-04 | 179 | 36 | 3 | 3b0f8781232e1d42b6f8913bc989a14b3f978e79 | |
| ToppCell | PND14-Endothelial-Endothelial_blood-vessel-Microvascular_EC-EPC-EPC_G2M|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.08e-04 | 180 | 36 | 3 | 5e1680088065be14447d5d5465f91f7edd071a1e | |
| ToppCell | 343B-Lymphocytic-NK_cells-NK_cell_A2|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 4.08e-04 | 180 | 36 | 3 | 62511d76d24b836839c3dcc2bf30485ffe9401e2 | |
| ToppCell | Hippocampus-Macroglia-POLYDENDROCYTE-P5|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 4.08e-04 | 180 | 36 | 3 | 44988c34861df359a68376500c42a64fbcc4b431 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2-Inh_L2-5_VIP_TOX2|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.15e-04 | 181 | 36 | 3 | 35bcdcd2651149692e5b150e887c0f450c81d2d4 | |
| ToppCell | Lymphoid-Lymphoid-T_cells_(cycle)|Lymphoid / shred on cell class and cell subclass (v4) | 4.15e-04 | 181 | 36 | 3 | b6b41cd5d43543fe7a093033dae52a789199db0e | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2-Inh_L2-5_VIP_TOX2|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.21e-04 | 182 | 36 | 3 | 3d7a8d2ee2137b098248597058974ef5ae09c19e | |
| ToppCell | cellseq-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal-Deuterosomal|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 4.21e-04 | 182 | 36 | 3 | deb53a4f84e4cd5c3b4180a4ac43249da9d738f7 | |
| ToppCell | E12.5-Mesenchymal-developing_mesenchymal_cell-mesenchymal_myogenic_precursor_(Axin2+)|E12.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 4.28e-04 | 183 | 36 | 3 | 523896bd1a93bdda81a009768baa3a1bdbd108b8 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2-Inh_L3-6_VIP_KCTD13|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.28e-04 | 183 | 36 | 3 | f06c06c75aab55fa8c803665afaa399446aec5af | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d02_child-Lymphocytic-Lymphocytic_B-Plasma_cell-B_c05-MZB1-XBP1|Mild-Moderate_progression_d02_child / Compartment, severity and other cell annotations on 10x 3' data (130k) | 4.35e-04 | 184 | 36 | 3 | af6522586d012e91241f3e06c60f9d1881e95646 | |
| ToppCell | Hippocampus-Macroglia|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 4.35e-04 | 184 | 36 | 3 | a1d039ddf1e2a87b870f3ce6d139be56090349df | |
| ToppCell | 3'-Broncho-tracheal-Immune_Lymphocytic-Lymphocytic_T/NK-T_cell-T_cells_proliferating-T_cells_proliferating_L.1.1.3.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.35e-04 | 184 | 36 | 3 | 8260e688ec42a1374727bc85dceb7edd19a8b662 | |
| ToppCell | 10x_3'_v3-spleen_(10x_3'_v3)-lymphocytic-T_lymphocytic-CD8-positive,_alpha-beta_T_cell|spleen_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 4.42e-04 | 185 | 36 | 3 | 9d424a8608b339dd6129c58d87626678d4ec4af7 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2-Inh_L2-5_VIP_TOX2|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.42e-04 | 185 | 36 | 3 | caf4f57f2db9ff72a652c8573e16e7ab180ffc05 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2-Inh_L1-3_VIP_GGH|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.56e-04 | 187 | 36 | 3 | eb011a3d8a3025cebb0fba36d403be906305372c | |
| ToppCell | Smart-seq2-tissue-resident_(Smart-seq2)-lymphocytic-T_lymphocytic-mature_NK_T_cell|tissue-resident_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 4.56e-04 | 187 | 36 | 3 | 931f9d16ce541bb6979f7f179bcae21816721294 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.63e-04 | 188 | 36 | 3 | c66fccdfe68760b8c3efca77e3c25966dc9a8a5f | |
| ToppCell | Hippocampus-Macroglia-POLYDENDROCYTE|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 4.63e-04 | 188 | 36 | 3 | 8bd6f2cd1aadbd6f9ed31b160f59c1eff144e1dc | |
| ToppCell | normal_Pleural_Fluid-T/NK_cells-Undetermined|normal_Pleural_Fluid / Location, Cell class and cell subclass | 4.78e-04 | 190 | 36 | 3 | 165c61443ff0c8efbdad3b052bb00f46d81c5203 | |
| ToppCell | 10x_3'_v2v3-Neoplastic-Differentiated-like-AC-like-AC-like_Prolif-C|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 4.85e-04 | 191 | 36 | 3 | 588015d76b68488da6aa6603777682f3d81592bf | |
| ToppCell | Endothelial-D_(cycle)|World / shred on cell class and cell subclass (v4) | 4.85e-04 | 191 | 36 | 3 | 49a4d8f181558e3be9527a8ff9a178f3bb01323c | |
| ToppCell | Endothelial-Endothelial-D_(cycle)|Endothelial / shred on cell class and cell subclass (v4) | 4.85e-04 | 191 | 36 | 3 | a3c5a913a99f17633c140ec9ece81b73e59e0715 | |
| ToppCell | 3'_v3-bone_marrow-Lymphocytic_T_CD4/8-lo-Cycling_T|bone_marrow / Manually curated celltypes from each tissue | 4.85e-04 | 191 | 36 | 3 | 210a0f1a71df2508cbfc73d6868a2122338b9a1c | |
| ToppCell | Myeloid-Myeloid-B_(Activated_Macrophage)|Myeloid / shred on cell class and cell subclass (v4) | 4.85e-04 | 191 | 36 | 3 | 7bf125249af1e8bb138ed4d999fdd74b03ab2447 | |
| ToppCell | E17.5-Endothelial-proliferative_endothelial_cell-proliferative_endothelial_cell|E17.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 4.85e-04 | 191 | 36 | 3 | efe0cb0b6602621f5eda72a723b83b38bf15607f | |
| ToppCell | E17.5-Endothelial-proliferative_endothelial_cell|E17.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 4.85e-04 | 191 | 36 | 3 | 00676c598f6dae0ff9158d064248f1265432f3e1 | |
| ToppCell | E17.5-Mesenchymal-developing_mesenchymal_cell-mesenchymal_proliferating_cell|E17.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 4.85e-04 | 191 | 36 | 3 | f764cc21fef87ebad765011098f647ae1bdf6158 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2-Inh_L1-3_VIP_GGH|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.85e-04 | 191 | 36 | 3 | 06760c3bb40e4f66879a5f5e09c9abfce4ebbba3 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.92e-04 | 192 | 36 | 3 | 6a252e298f8a454623fa9c1c893a7a45a886d694 | |
| ToppCell | droplet-Lung-30m-Hematologic-myeloid-classical_monocyte_proliferating-classical_monocyte_proliferating_l12-14|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.92e-04 | 192 | 36 | 3 | 52d0aa51e3b6ab3608a5f40bdde9f8134b3afd94 | |
| ToppCell | droplet-Thymus-nan-3m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.92e-04 | 192 | 36 | 3 | 041124dd5c24c1eb188d2560ba606422c0b215c5 | |
| ToppCell | 10x_3'_v2v3-Neoplastic-Stem-like-NPC-like-NPC-like_Prolif-D|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 4.92e-04 | 192 | 36 | 3 | f518839ecd9377537a414e8798766f7d91eafeac | |
| ToppCell | tumor_Lymph_Node_/_Brain-T/NK_cells-Undetermined|tumor_Lymph_Node_/_Brain / Location, Cell class and cell subclass | 4.92e-04 | 192 | 36 | 3 | 3856c4d611224cd6c2558631147cd5333bc0ccb7 | |
| ToppCell | E15.5|World / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 4.92e-04 | 192 | 36 | 3 | 4a0fb4ef8a9281489ffb0881421c9d691c52019c | |
| ToppCell | droplet-Thymus-nan-3m|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.92e-04 | 192 | 36 | 3 | d9e61b2722aa81e4f6e11865a04f2f1e75b794ab | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.92e-04 | 192 | 36 | 3 | 025fac36b862f9ca7f96fb4a1946c44ba7cbc382 | |
| ToppCell | PBMC-Control-cDC_6|Control / Compartment, Disease Groups and Clusters | 4.92e-04 | 192 | 36 | 3 | 41a7201febb7d88a39e4ee64df04cce18c691df8 | |
| ToppCell | P07-Endothelial-proliferative_endothelial_cell|P07 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 5.00e-04 | 193 | 36 | 3 | 1e95ef29357969ee385b4717c0b5a497390ac260 | |
| ToppCell | PND07-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-SCMF-SCMF_G2M|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.00e-04 | 193 | 36 | 3 | a332dfdcc48c405020014e644aa4d14fda98cc86 | |
| ToppCell | facs-Thymus-Flowthrough-24m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.00e-04 | 193 | 36 | 3 | fd5a5ead966abe385a22d61a721f9fb1605876f6 | |
| ToppCell | droplet-Lung-30m-Hematologic-myeloid-classical_monocyte_proliferating-classical_monocyte_proliferating_l2|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.00e-04 | 193 | 36 | 3 | 4a3e456f07e521519faeb9153e8d571cb8fbeaf9 | |
| ToppCell | P07-Endothelial-proliferative_endothelial_cell-proliferative_endothelial_cell|P07 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 5.00e-04 | 193 | 36 | 3 | 0f21fb8b35f89f4c1c8109d1a4d3d08a452f9edd | |
| ToppCell | droplet-Tongue-nan-3m-Epithelial-proliferating|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.08e-04 | 194 | 36 | 3 | 2cac1b9c4da01faaec9a67ec06f47a7060760225 | |
| ToppCell | facs-Thymus-Flowthrough-24m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.08e-04 | 194 | 36 | 3 | 5d60262a512590d60bc795d9a0e03c0219e3e15e | |
| ToppCell | P03-Endothelial-proliferative_endothelial_cell|P03 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 5.08e-04 | 194 | 36 | 3 | 22bcfb0f3f73608feb22c0847ab4d34f87aeede0 | |
| ToppCell | P03-Endothelial-proliferative_endothelial_cell-proliferative_endothelial_cell|P03 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 5.08e-04 | 194 | 36 | 3 | 5e56ce9b9fe0721be3a9e6efe1422599bb867721 | |
| ToppCell | droplet-Lung-30m-Hematologic-myeloid-classical_monocyte_proliferating|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.08e-04 | 194 | 36 | 3 | 5810d8e1f6b983bb346fe06dda22b8ba3f2144a6 | |
| ToppCell | control-Lymphocytic-Prol._cells|control / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 5.08e-04 | 194 | 36 | 3 | 4c76508de3291c952386caffda2d559629ba5998 | |
| ToppCell | Control-Lymphocyte-T_NK-T_NK_proliferative|Control / Disease, Lineage and Cell Type | 5.08e-04 | 194 | 36 | 3 | 844731b7943d1cfca819b7b89e4e62067bfa0230 | |
| ToppCell | facs-Thymus-Thymus_Flowthrough-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.15e-04 | 195 | 36 | 3 | e9c7eb0b1a2d58f69b4e839665101948bd4527b8 | |
| ToppCell | mild-Lymphocytic-Prol._cells|mild / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 5.15e-04 | 195 | 36 | 3 | 9a8cc9097a349fd0a53ccf2723ee8bb1418d6aca | |
| ToppCell | droplet-Thymus-nan-3m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.15e-04 | 195 | 36 | 3 | 7ae732f100e9a3c6062be5b877efa1ec9d5b3958 | |
| ToppCell | droplet-Thymus-nan-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.15e-04 | 195 | 36 | 3 | 043e2f19d95e94cd5219e2c415f322ed340aa80f | |
| ToppCell | E18.5-Endothelial-Endothelial_blood-vessel-Microvascular_EC-EPC-EPC_G2M|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.15e-04 | 195 | 36 | 3 | a838bddeed487154791b69d27a68673783ff63c0 | |
| ToppCell | control-immature_Neutrophil|control / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 5.23e-04 | 196 | 36 | 3 | e34fd3e7a5b1c22a81fd3208e6d58bdb846d51c4 | |
| ToppCell | medial-Endothelial-Capillary_Intermediate_2|medial / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 5.23e-04 | 196 | 36 | 3 | 07e6214e771c65574f0ada65e75f4bda265aa47f | |
| ToppCell | PND10-Endothelial-Endothelial_blood-vessel-Microvascular_EC-EPC-EPC_G2M|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.23e-04 | 196 | 36 | 3 | 20383d576708b7e4bfce3e9fe40548cce496e3cb | |
| ToppCell | medial-2-Endothelial-Capillary_Intermediate_2|2 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 5.23e-04 | 196 | 36 | 3 | d074c24fecd0e3ffca4699fb1a9d443e6d9a858d | |
| ToppCell | medial-Endothelial-Capillary_Intermediate_2-2|medial / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 5.23e-04 | 196 | 36 | 3 | 5cc14a5797884ff3a007683048e690a0d7172fc4 | |
| ToppCell | droplet-Thymus-nan-18m-Lymphocytic-DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.23e-04 | 196 | 36 | 3 | 5ddd314d3def3776dc7da83778d41c6436ca51ac | |
| ToppCell | ILEUM-non-inflamed-(5)_Plasma-(5)_Plasmablasts|(5)_Plasma / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 5.31e-04 | 197 | 36 | 3 | ffc55028052311ed8d173a2db1a9f664391fe8d8 | |
| ToppCell | E16.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-PMP-PMP_G2M|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.31e-04 | 197 | 36 | 3 | 29b0a5927f80455eef7b793feabef69fba1a3df1 | |
| ToppCell | droplet-Thymus-nan-3m-Lymphocytic-DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.31e-04 | 197 | 36 | 3 | 9b2c67de46bd59bf56c81a0d10b84cf4a041c120 | |
| ToppCell | H1299-infected-SARSCoV2|infected / Cell line, Condition and Strain | 5.31e-04 | 197 | 36 | 3 | 0fa3e4cf93e77d78b1f97b906c5b13ca741ae17e | |
| ToppCell | droplet-Thymus-nan-21m-Lymphocytic-DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.31e-04 | 197 | 36 | 3 | f84f0ddf51208764ab56408d97035bbff562e59d | |
| ToppCell | PND07-Endothelial-Endothelial_blood-vessel-Microvascular_EC-EPC-EPC_G2M|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.31e-04 | 197 | 36 | 3 | 1c89d6836eed30c50c765f7dde9cc8ee15c363d2 | |
| ToppCell | droplet-Thymus-nan-21m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.31e-04 | 197 | 36 | 3 | a0d463825b62de49466f9fa563405dda4387cfff | |
| ToppCell | PND07-Endothelial-Endothelial_blood-vessel-Microvascular_EC-EPC|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.31e-04 | 197 | 36 | 3 | a41420d4b6d502c2f594c054c7efbb5d4eac83ff | |
| Computational | Neighborhood of HDAC1 | 7.84e-05 | 38 | 24 | 3 | GCM_HDAC1 | |
| Computational | Neighborhood of PFN1 | 1.90e-04 | 51 | 24 | 3 | GCM_PFN1 | |
| Computational | Neighborhood of SMC1L1 | 3.39e-04 | 62 | 24 | 3 | MORF_SMC1L1 | |
| Computational | Neighborhood of CBFB | 4.85e-04 | 70 | 24 | 3 | GCM_CBFB | |
| Computational | Neighborhood of PSME1 | 8.57e-04 | 85 | 24 | 3 | GCM_PSME1 | |
| Computational | Genes in the cancer module 189. | 1.17e-03 | 23 | 24 | 2 | MODULE_189 | |
| Computational | Genes in the cancer module 127. | 1.50e-03 | 26 | 24 | 2 | MODULE_127 | |
| Computational | Neighborhood of APEX1 | 2.00e-03 | 114 | 24 | 3 | GCM_APEX1 | |
| Computational | Neighborhood of ERH | 2.05e-03 | 115 | 24 | 3 | MORF_ERH | |
| Computational | Neighborhood of EIF3S6 | 2.43e-03 | 122 | 24 | 3 | MORF_EIF3S6 | |
| Computational | Neighborhood of DEK | 2.57e-03 | 264 | 24 | 4 | MORF_DEK | |
| Computational | Neighborhood of RAN | 2.71e-03 | 268 | 24 | 4 | MORF_RAN | |
| Computational | Neighborhood of ANP32B | 2.87e-03 | 36 | 24 | 2 | GCM_ANP32B | |
| Computational | Neighborhood of RAD21 | 3.03e-03 | 37 | 24 | 2 | GCM_RAD21 | |
| Disease | diet measurement, fasting blood insulin measurement | 2.60e-04 | 22 | 32 | 2 | EFO_0004466, EFO_0008111 | |
| Disease | diet measurement, HOMA-IR | 2.84e-04 | 23 | 32 | 2 | EFO_0004501, EFO_0008111 | |
| Disease | Hematopoetic Myelodysplasia | 4.54e-04 | 29 | 32 | 2 | C2713368 | |
| Disease | response to platinum based chemotherapy, drug allergy | 7.01e-04 | 36 | 32 | 2 | EFO_0004647, EFO_0009482 | |
| Disease | corpus callosum anterior volume measurement | 8.23e-04 | 39 | 32 | 2 | EFO_0010295 | |
| Disease | Intellectual Disability | 1.34e-03 | 447 | 32 | 4 | C3714756 | |
| Disease | MYELODYSPLASTIC SYNDROME | 2.41e-03 | 67 | 32 | 2 | C3463824 | |
| Disease | pulmonary hypertension (biomarker_via_orthology) | 3.42e-03 | 80 | 32 | 2 | DOID:6432 (biomarker_via_orthology) | |
| Disease | response to selective serotonin reuptake inhibitor | 3.58e-03 | 82 | 32 | 2 | EFO_0005658 | |
| Disease | acute myeloid leukemia (is_implicated_in) | 3.76e-03 | 84 | 32 | 2 | DOID:9119 (is_implicated_in) | |
| Disease | Autism Spectrum Disorders | 3.85e-03 | 85 | 32 | 2 | C1510586 | |
| Disease | alcoholic pancreatitis | 5.08e-03 | 98 | 32 | 2 | EFO_1002013 | |
| Disease | corpus callosum volume measurement | 5.28e-03 | 100 | 32 | 2 | EFO_0010299 | |
| Disease | Adenoid Cystic Carcinoma | 5.28e-03 | 100 | 32 | 2 | C0010606 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| PEEDDDEDEEDDDDL | 2536 | Q9HCK8 | |
| EDNEAPDSEEEDDED | 151 | Q9BTT0 | |
| PDSEEEDDEDGDEDD | 156 | Q9BTT0 | |
| HDLPEEDFEDDGDDE | 296 | Q96MI9 | |
| YPDDDEDDDEDEDKE | 806 | Q6IN85 | |
| DSGAEEEEDEDDDEP | 21 | Q9Y4X5 | |
| EEEDEDDDEPDDDTL | 26 | Q9Y4X5 | |
| EDAIPEESGDEDEDD | 386 | Q13547 | |
| EEEEDEDHGPDDYDE | 26 | Q8IV16 | |
| EDHGPDDYDEEDEDE | 31 | Q8IV16 | |
| EDDDDDDEGEDDGEE | 151 | Q0VAK6 | |
| GDTPGAEDDEEDDDE | 101 | Q9UQF2 | |
| PDGVLESDDDEDEDD | 576 | Q7Z3E5 | |
| EDEDEEEDEEAAAPG | 1281 | Q96Q04 | |
| YNDDDDDDDGDDPEE | 181 | Q15910 | |
| GPPDYDEDDDDDSDE | 101 | Q8WY41 | |
| DESGDTDDPEEEEEE | 1031 | Q14432 | |
| SREDEEEDDDDPEDE | 41 | Q9NP08 | |
| EEDDDDPEDEDAEQA | 46 | Q9NP08 | |
| PGGDEEEDEEEEEED | 71 | Q1KMD3 | |
| DEEDDQEDDEGEEGD | 2441 | Q7Z6Z7 | |
| QEDDEGEEGDEDDDD | 2446 | Q7Z6Z7 | |
| DEEEEEDEDDDEGPY | 421 | Q9HC58 | |
| APASEDEDDEDDEDD | 181 | P19338 | |
| AEPLEEDEEGDDEFD | 46 | Q9UMY1 | |
| EDEEGDDEFDDEAPE | 51 | Q9UMY1 | |
| DEEEDEESDDADDTP | 1106 | Q92794 | |
| DEDDDDDEEDGDEVP | 526 | P07199 | |
| DDDEDLPEPDEEDDE | 1676 | Q9ULT8 | |
| EEEEDDDDDDDPTER | 1016 | O75054 | |
| DGDGEDEEDVDDEED | 81 | Q96HJ3 | |
| EDDDDDEDDPAEAEK | 201 | Q7L014 | |
| ESGDQEDEDDESEDP | 941 | O60763 | |
| SGDEVPDDEDDDEDE | 186 | Q15270 | |
| PDDEDDDEDEAPETE | 191 | Q15270 | |
| PDMDDEEGGEDDDDD | 246 | P0DME0 | |
| DDDDDDDDGDEGEEE | 256 | P0DME0 | |
| PDMDDEEGEGEEDDD | 236 | Q01105 | |
| APEDDDEDDDEELLE | 161 | O15370 | |
| RPDGSEDAEDDDDDD | 351 | O14787 | |
| VAGDDDDDDDDSPDP | 116 | O00193 | |
| EEEEGRDPDDDEEED | 756 | Q2VWA4 | |
| DEDDPDEGDDDSLSE | 701 | Q9UHJ3 | |
| SEDNDEPGDEDEEDE | 111 | Q9UL68 | |
| EPGDEDEEDEEGDRE | 116 | Q9UL68 | |
| EEDDEDDEEDGEPPY | 411 | Q96SB3 |